Cell-based therapies are changing the paradigm for treating diseases and injuries. However, there is a need for reliable methods to assess attributes of cell-based products. Regulatory filings contain many types of measurement data to define product quality, safety and efficacy. For mammalian cells, measurements of cell count, viability, and function are major parts of these datasets. In addition, there is the need to advance our measurement technologies to better support product characterization and assist the development and monitoring of manufacturing pipelines. At BBD, we develop measurement assurance strategies and technologies to improve confidence in cell measurements that support standards development, and we also engage in basic research that enables characterization and commercialization of cell-based products.